Johnson & Johnson · 8 hours ago
Summer 2026 - PK/PD intern
Spring House, Pennsylvania, United States of America
Internship
Hybrid
Intern
Start in 2026 SummerJohnson & Johnson is a leader in healthcare innovation, seeking a PhD-level intern to support quantitative modeling for novel therapeutic modalities within the Translational PK/PD organization. The intern will collaborate with scientists to analyze data, build models, and generate insights for autoimmune disease programs.
Hospital & Health Care
No H1B
U.S. Citizen Only
Responsibilities
Conduct literature searches and extract publicly available datasets relevant to a novel modality in autoimmune indications
Identify exposure–response metrics and support development of empirical and/or mechanistic models for novel modality system behavior
Analyze nonclinical PK datasets to determine empirical scaling factors for human dose projections
Develop and evaluate quantitative hypotheses to determine PD benchmarks required for functional cure for novel treatment modality
Summarize findings and present results to project and functional teams
Qualification
Required
Current PhD student in Pharmacometrics, Systems Pharmacology, Immunology, Biomedical/Chemical Engineering, Computational Biology, or related field
Experience with PK/PD or systems modeling (R, Python, MATLAB, or similar)
Strong scientific, quantitative, and communication skills
Permanently authorized to work in the U.S., must not require sponsorship of an employment visa (e.g., H-1B or green card) at the time of application or in the future
Company
Johnson & Johnson
At Johnson & Johnson, we believe health is everything.
Founded in 1886
10001+ employees
Funding
Current Stage
Late StageLeadership Team
Alex Gorsky
Former Chairman and CEO, Johnson & Johnson
Joaquin Duato
Chairman of the Board and Chief Executive Officer
Recent News
2025-10-07
2025-10-07
Company data provided by crunchbase